This needs to be first for reverse chronological order.
比如：
Ye Liu, Jen-Chien Chang, Chung-Chau Hon, Naoshi Fukui, Nobuho Tanaka, Zhenya Zhang, Ming Ta Michael Lee, and Aki Minoda. "Chromatin accessibility landscape of articular knee cartilage reveals aberrant enhancer regulation in osteoarthritis”. Genome Medicine. 2017. In submission.
What does in submission mean? 盡量避免 “in submission” 聽起來太slippery
- It has to be either
(i) manuscript in preparation,
(ii) submitted,
(iii) under review or
(iv) in revision.
添加這些還沒有發(fā)表的文章只是為了提高CV的重量宪卿，切記不要撒謊，in submission 聽起來雖然比 (i) manuscript in preparation 高大上，但其實(shí)在reviwer眼里幾乎就是沒有的狀態(tài)辩撑。以上幾種狀態(tài)是一個PI給我的建議宛渐，我當(dāng)時寫的是in submission竞漾，不建議我這樣寫。
如果手稿已經(jīng)寫好了窥翩，真的就是這兩天（幾周）就要投稿了业岁，但是還沒有(ii) submitted，個人建議可以把manuscript投到Preprint的Biorxiv中寇蚊。這樣可以增加可信度笔时。不知道Biorxiv的同學(xué)自己戳連接或者自己知乎一下。
那么手稿已經(jīng)投到了biorxiv中了怎么寫這個狀態(tài)呢仗岸？
可以在最后用括號寫上Manuscript is deposited on bioRxiv
Ye Liu, Jen-Chien Chang, Chung-Chau Hon, Naoshi Fukui, Nobuho Tanaka, Zhenya Zhang, Ming Ta Michael Lee, and Aki Minoda. "Chromatin accessibility landscape of articular knee cartilage reveals aberrant enhancer regulation in osteoarthritis”. Scientific Reports. 2018. In revision. (Manuscript is deposited on bioRxiv.)
注意：本文所寫的文章狀態(tài)并不屬實(shí)允耿，只是寫的例子而已，供參考扒怖。有更好的意見的同學(xué)歡迎留言较锡。
